Lucid Diagnostics Inc. Convertible Notes Payable, Current
Lucid Diagnostics Inc. (LUCD) had Convertible Notes Payable, Current of $23.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-12
- 2026-06-30: Convertible Notes Payable, Current $23.50M.
- 2026-03-31: Convertible Notes Payable, Current $25.20M.
- 2025-12-31: Convertible Notes Payable, Current $24.00M.
- 2025-09-30: Convertible Notes Payable, Current $22.30M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-06-30 | $23.50M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $25.20M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $24.00M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $22.30M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $25.30M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $32.80M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $18.60M 10-K · filed 2026-03-25 |
| 2024-09-30 | $10.20M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $11.20M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $13.14M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $13.95M 10-K · filed 2025-03-24 |
| 2023-09-30 | $14.49M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $11.61M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.90M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |